Dr. Gary Chadwick is an Associate Provost at the University of Rochester and Professor of Clinical Community and Preventive Medicine and Medical Humanities in the School of Medicine and Dentistry. He is the Director of the Office for Human Subject Protection, which is responsible for the operation and support of the University's Institutional Review Board (IRB) system. His office also operates the investigator ethics training program and a quality improvement program. He develops, teaches and implements training programs for faculty, staff and students in research ethics. He is the co-author of the widely used training manual for investigators, "Protecting Study Volunteers in Research" (CenterWatch, 3rd ed. 2004). Gary regularly conducts training sessions and program audits for universities, hospitals and professional societies.

Dr. Chadwick is a past President of Applied Research Ethics National Association (ARENA) - the national association for IRBs. Gary was the founding Chair of the Council for Certification of IRB Professionals (CCIP). He has served on National Institutes of Health study sections in research ethics and he is a subject matter expert for the HHS Office for Human Research Protection (OHRP). Gary has served as Chair of the National Committee for Quality Assurance (NCQA) Human Research Protection Advisory Council, and as a consultant to the State of New York and various federal agencies on issues of research ethics and regulation. He has been a member of two national subcommittees of the Secretary's (HHS) Advisory Committee on Human Research Protections (SACHRP). Currently, he serves on the Subpart A Subcommittee, which is evaluating the regulations for the basic protections of human research subjects' informed consent and IRB review.

Before joining the University of Rochester in 1996, Dr. Chadwick was a commissioned officer in the U.S. Public Health Service (PHS) for over 26 years. He served in many PHS agencies, including the Food and Drug Administration (FDA) where he was the Associate Director for Human Subject Protection in the Office of the Commissioner and a Senior Scientific Reviewer in the Division of Scientific Investigations of the FDA's Center for Drug Evaluation and Research, where he worked with Dr. Frances Kelsey, of Thalidomide fame. Gary has also worked for the Office for Protection from Research Risks (OPRR) when it was housed at the National Institutes of Health and run by Dr. Charles McCarthy. He earned his Bachelor of Science in Pharmacy from the Ohio State University, his Doctor of Pharmacy in clinical psychopharmacology from the University of Tennessee, and his Masters in Public Health (ethics and administration) from the Uniformed Services University.

• Dorsey ER, Beck CA, Adams M, Chadwick G, de Blieck EA, McCallum C, Briner L, Deuel L, Clarke A, Stewart R, Shoulson I. Communicating clinical trial results to research participants. Arch Neurol. 2008 Dec; 65(12):1590-5.
  View in: PubMed
• McIntosh S, Sierra E, Dozier A, Diaz S, Quiñones Z, Primack A, Chadwick G, Ossip-Klein DJ. Ethical review issues in collaborative research between us and low-middle income country partners: a case example. Bioethics. 2008 Sep; 22(8):414-22.
  View in: PubMed
• Wagner TH, Cruz AM, Chadwick GL. Economies of scale in institutional review boards. Med Care. 2004 Aug; 42(8):817-23.
  View in: PubMed
• Wagner TH, Bhandari A, Chadwick GL, Nelson DK. The cost of operating institutional review boards (IRBs). Acad Med. 2003 Jun; 78(6):638-44.
  View in: PubMed
• Chadwick GL. Clinical trials in the 21st century: a global approach. Res Nurs Health. 2001 Dec; 24(6):541-2.
  View in: PubMed
• Chadwick GL, Dunn CM. Institutional review boards: changing with the times? J Public Health Manag Pract. 2000 Nov; 6(6):19-27.
  View in: PubMed
• Chadwick GL. Historical perspective: Nuremberg, Tuskegee, and the radiation experiments. J Int Assoc Physicians AIDS Care. 1997 Jan; 3(1):27-8.
  View in: PubMed
• Chadwick GL. Psychiatric pharmacy residency and services. Mil Med. 1976 Aug; 141(8):537-9.
  View in: PubMed